Posted on 08. Sep, 2009 by cyndynayer in News
Mayo, a member of the Center’s Board of Advisors, has asked us to share some new tools and evidence with you. Here’s the info on some of their new programs and evidence. Mayo White Paper update 0709 If you click on Mayo Tools you’ll be taken to their site. Another example of sharing the information of value-based designs!
Posted on 04. Sep, 2009 by cyndynayer in Library, News
We are delighted to share a new white paper with you, Value-Based Design in Action: Cities, Counties, State. In this paper, we share the journeys of 2 cities [Springfield OR and Battle Creek MI], 2 counties [Polk County FL and Chippewa County WI], and the State of Maine. Each took a very different approach to health and economic improvement using value-based designs.
Posted on 24. Jul, 2009 by admin in Library
New data from the New England Journal of Medicine shows reduction in prescription costs can reduce non-adherence in Medicare, BUT…
The research in the NEJM shows that patients can be encouraged to adhere to their medication and management regimens through a reduction the costs of their medications, despite the investment needed to lower the costs. However, those who already had rich benefits tended to extend their use of health resources, an “unintended consequence.” This may be the fuel for precision-focused value-based designs.
Read the free full-text report from the NEJM.
Posted on 09. Jun, 2009 by cyndynayer in Library
We’re pleased to highlight this new research demonstrating the positive results of value-based benefit design. Dr. Robert Scully, a board member of the Center for Health Value Innovation, is one of the people at the forefront of this research. Here’s the press release:
MedImpact Study Highlights Effects of Value-Based Benefit Design on Adherence to Diabetes Medications
New Research Showing VBBD Implementation Improves Adherence Presented at ISPOR International Conference
San Diego, Calif., June 2, 2009—MedImpact researchers and Health Alliance Medical Plans, a MedImpact client, presented findings from an important new study that evaluates the impact of value-based benefit design (VBBD) on adherence to diabetes medications. Study results show that implementation of a VBBD program that reduced copayment by almost fifty percent for diabetic medications resulted in significantly improved medication adherence.
VBBD, also known as value-based insurance design, is a new pharmacy benefit design that defines drug copay on clinical value rather than drug acquisition cost. The rationale behind VBBD is that many important treatments for chronic illnesses, such as diabetes and asthma, are often underused due to cost, leading to undesirable patient outcomes such as an increase in complications and preventable hospitalizations. The purpose of this research was to evaluate the impact of a VBBD on adherence to diabetes medications among a pilot group of Carle Clinic enrollees.
The program reduced copayment for diabetic medications by 47.6 percent and improved the odds of adherence by 73.3 percent. The number of non-adherent patients was reduced by 33.4 percent.
“This study adds to a growing body of evidence that shows adherence to treatment is higher when there are lower copays,” said Dr. Robert Scully, senior medical director for Health Alliance Medical Plans. “Companies such as Pitney Bowes have reported that improved adherence after introduction of a VBBD for diabetic medications was followed by lower overall claim costs in their diabetic population. Our goal is to prove this in an insured population, and the pilot data we are reporting now is very encouraging.”
The MedImpact study—“The Impact of Formulary Value-Based Insurance Design on Adherence to Diabetes Medications: A Propensity Score Matched Difference in Difference Evaluation”—was presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 14th Annual International Meeting on Tuesday, May 19.
“ISPOR is an innovative, vital organization that supports the science of health economics and the effects of health care interventions on patient well-being,” said Dr. Louis Brunetti, senior vice president and chief medical officer for MedImpact. “The research presented during the annual meeting is translated into valuable information for health care decision-makers and ultimately helps to better allocate scarce health care resources.”
ISPOR represents researchers and practitioners, including pharmacists, physicians, and economists. The research findings benefit all members of the health care continuum, including hospitals, patients and managed care and pharmacy benefit design organization’s personnel, who use the information to make better informed health care decisions.
Posted on 01. Mar, 2009 by admin in News
The March 1 issue of Managed Healthcare Executive features an article by Cyndy Nayer, CHVI president. Among her recommendations:
- Quantify the current risk to their organization in order to deploy focused incentives for behavior change and measure results;
- Measure emerging risks among those with chronic disease and create incentives to reduce or delay more critical and (financially catastrophic) phases of illness; and
- Design incentives to keep the healthy population at low risk.
She concludes by telling executives, “The bottom line is that a healthy employee is a competitive business advantage.”
Read the full article.
